Cedars-Sinai

Physician Hosts Forum to Help Caregivers Share COVID-19 Feelings

Front Line Healthcare Professionals Invited to Communicate COVID-19 Experiences in Creative Ways
30-Jul-2020 4:05 PM EDT, by Cedars-Sinai contact patient services

Newswise — Cedars-Sinai palliative care physician Erin Reeve, MD, will host a virtual "open mic night" for healthcare professionals who have been working on the front lines of the COVID-19 pandemic so they can share their stories and feelings in creative ways.

The Zoom open mic, taking place on Saturday, Aug. 1, invites any healthcare professional to share a piece of writing, poetry, music or art that reflects on their role during the pandemic. 

"This is not about being a stellar performer or artist. It's about using your voice and being heard, and being witness to each other's experiences with colleagues across the nation who are likely feeling many similar emotions," Reeve said. 

Anyone can attend the virtual forum, but the microphone will be open only to front line healthcare professionals. This event is hosted by Reimagine, a nonprofit organization dedicated to creating conversations about processing loss, life, grief, and healing.

Reeve said she got involved with the organization after meeting the founder at a conference where he played and sang a song he wrote, and told about a friend who had died who had inspired his vision for Reimagine.

"As a musician and palliative care doctor, I connected with using the creative arts to facilitate dialogue about difficult issues like end of life and loss," said Reeve, who plays the piano and several other instruments.

Reeve said events like this help foster important connections at a time when even a hug at the end of a long day is dangerous. 

"The first time I went to a virtual event like this, I was skeptical about how connected I was going to feel to a group of strangers through a screen," she said. "But there was something powerful that happened in simply being present for each other and finding commonality in our human experience that made the screen become less of a barrier. It lifted me, and for a moment I did feel less isolated." 

To find out more about the event and to RSVP, visit Reimagine's website here

Read more on the Cedars-Sinai Blog: Handmade Blankets Bring Extra Comfort to Hospice Patients




Filters close

Showing results

110 of 2785
Newswise: Coronavirus Drug for Cats Has Potential Use for COVID-19 Virus in Humans
28-Jul-2020 9:50 AM EDT
Coronavirus Drug for Cats Has Potential Use for COVID-19 Virus in Humans
American Crystallographic Association (ACA)

Researchers at the University of Alberta say a protease in SARS-CoV-2 can be targeted with a drug that is also used to treat feline infectious peritonitis, a fatal infection in cats caused by a coronavirus. The drugs, dipeptide-based protein inhibitors, could be used to slow or stop replication of the COVID-19 virus in humans. During the 70th annual meeting of the American Crystallographic Association, Joanne Lemieux will outline how the drugs are strong candidates for the treatment of human coronavirus infections.

Released: 4-Aug-2020 1:40 PM EDT
Tip Sheet: COVID-19 vaccines, COVID-19 and cancer patients, smoking cessation apps, structural racism in medicine – and more
Fred Hutchinson Cancer Research Center

Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.

Newswise: Story Tips: Pandemic impact, root studies, neutrons confirm, lab on a crystal and modeling fusion
Released: 4-Aug-2020 1:25 PM EDT
Story Tips: Pandemic impact, root studies, neutrons confirm, lab on a crystal and modeling fusion
Oak Ridge National Laboratory

ORNL Story Tips: Pandemic impact, root studies, neutrons confirm, lab on a crystal and modeling fusion

Newswise: How Countries Are Reopening Schools During the Pandemic
Released: 4-Aug-2020 1:20 PM EDT
How Countries Are Reopening Schools During the Pandemic
Council on Foreign Relations (CFR)

Educators worldwide are facing the agonizing decision of whether to resume in-person instruction while there’s still no cure for the new coronavirus. Countries including Denmark, India, and Kenya are taking different approaches.

Released: 4-Aug-2020 11:55 AM EDT
ACTG Announces Launch of Novel Clinical Trial Testing Multiple Therapeutics to Treat COVID-19
University of California, Los Angeles (UCLA), Health Sciences

The AIDS Clinical Trials Group (ACTG) has initiated the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial. ACTIV-2 includes both phase 2 and phase 3 evaluations of multiple promising investigational agents for treating early COVID-19 in a single trial.

Newswise:Video Embedded covid-19-study-confirms-low-transmission-in-educational-settings2
VIDEO
Released: 4-Aug-2020 11:20 AM EDT
COVID-19 study confirms low transmission in educational settings
University of Sydney

The rate of COVID-19 transmission in New South Wales (NSW) educational settings was extremely limited during the first wave of COVID-19, research findings published today in The Lancet Journal of Child and Adolescent Health have shown.

Newswise: Droplet Spread from Humans Doesn’t Always Follow Airflow
31-Jul-2020 3:15 PM EDT
Droplet Spread from Humans Doesn’t Always Follow Airflow
American Institute of Physics (AIP)

If aerosol transmission of COVID-19 is confirmed to be significant, as suspected, we will need to reconsider guidelines on social distancing, ventilation systems and shared spaces. Researchers in the U.K. believe a better understanding of different droplet behaviors and their different dispersion mechanisms is also needed. In Physics of Fluids, the group presents a model that demarcates differently sized droplets. This has implications for understanding the spread of airborne diseases, because the dispersion tests revealed the absence of intermediate-sized droplets.

Released: 4-Aug-2020 10:30 AM EDT
COVID-19 study confirms low transmission in educational settings
University of Sydney

The rate of COVID-19 transmission in New South Wales (NSW) educational settings was extremely limited during the first wave of COVID-19, research findings published today in The Lancet Journal of Child and Adolescent Health have shown.

Newswise: Researchers develop new mouse model for SARS-CoV-2
Released: 4-Aug-2020 10:00 AM EDT
Researchers develop new mouse model for SARS-CoV-2
The Rockefeller University Press

Researchers at Yale University School of Medicine have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus. The study, published today in the Journal of Experimental Medicine (JEM), also suggests that, rather than protecting the lungs, key antiviral signaling proteins may actually cause much of the tissue damage associated with COVID-19.


Showing results

110 of 2785

close
2.18761